2026 26110_MCW Pancreatic Cancer Symposium: Advancing Precision Medicine Evaluation

1 Start 2 Complete

Overall Symposium

Please rate the 15th Annual Pancreatic Cancer Symposium on the following:

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree
Overall, the symposium met my expectations.	Overall, the symposium met my expectations. - Strongly Agree	Overall, the symposium met my expectations. - Agree	Overall, the symposium met my expectations. - Neither Agree nor Disagree	Overall, the symposium met my expectations. - Disagree	Overall, the symposium met my expectations. - Strongly Disagree
The content of the symposium met my expectations.	The content of the symposium met my expectations. - Strongly Agree	The content of the symposium met my expectations. - Agree	The content of the symposium met my expectations. - Neither Agree nor Disagree	The content of the symposium met my expectations. - Disagree	The content of the symposium met my expectations. - Strongly Disagree
The format was conducive to the meeting.	The format was conducive to the meeting. - Strongly Agree	The format was conducive to the meeting. - Agree	The format was conducive to the meeting. - Neither Agree nor Disagree	The format was conducive to the meeting. - Disagree	The format was conducive to the meeting. - Strongly Disagree
The location of the meeting was convenient.	The location of the meeting was convenient. - Strongly Agree	The location of the meeting was convenient. - Agree	The location of the meeting was convenient. - Neither Agree nor Disagree	The location of the meeting was convenient. - Disagree	The location of the meeting was convenient. - Strongly Disagree

Sessions

Please evaluate the content of each of the following sessions/discussions

	Extremely Satisfied	Satisfied	Neither Satisfied nor Dissatisfied	Dissatisfied	Did Not Attend
"Welcome & Introduction" - Douglas B. Evans, MD	"Welcome & Introduction" - Douglas B. Evans, MD - Extremely Satisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Satisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Neither Satisfied nor Dissatisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Dissatisfied	"Welcome & Introduction" - Douglas B. Evans, MD - Did Not Attend
"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS	"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS - Extremely Satisfied	"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS - Satisfied	"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS - Neither Satisfied nor Dissatisfied	"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS - Dissatisfied	"Expanding Precision Therapeutic Frontiers in Pancreatic Cancer" - Wungki Park, MD, MS - Did Not Attend
"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD	"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD - Extremely Satisfied	"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD - Satisfied	"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD - Neither Satisfied nor Dissatisfied	"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD - Dissatisfied	"The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma" - Tommy McFall PhD & David Seo, MD - Did Not Attend
"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH	"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH - Extremely Satisfied	"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH - Satisfied	"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH - Neither Satisfied nor Dissatisfied	"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH - Dissatisfied	"The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy" - Mandana Kamgar, MD, MPH - Did Not Attend
"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD	"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD - Extremely Satisfied	"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD - Satisfied	"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD - Neither Satisfied nor Dissatisfied	"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD - Dissatisfied	"Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning?" - Marcus Tan, MD - Did Not Attend
"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS	"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS - Extremely Satisfied	"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS - Satisfied	"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS - Neither Satisfied nor Dissatisfied	"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS - Dissatisfied	"Emerging Role of ctDNA in Pancreatic Cancer" - Susan Tsai, MD, MHS - Did Not Attend
"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS	"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS - Extremely Satisfied	"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS - Satisfied	"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS - Neither Satisfied nor Dissatisfied	"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS - Dissatisfied	"AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma" - Anai Kothari, MD, MS - Did Not Attend
"Closing Remarks" - Douglas B. Evans, MD	"Closing Remarks" - Douglas B. Evans, MD - Extremely Satisfied	"Closing Remarks" - Douglas B. Evans, MD - Satisfied	"Closing Remarks" - Douglas B. Evans, MD - Neither Satisfied nor Dissatisfied	"Closing Remarks" - Douglas B. Evans, MD - Dissatisfied	"Closing Remarks" - Douglas B. Evans, MD - Did Not Attend

Participation

I attended this symposium for the opportunity to (Check all that apply):

Network with other medical professionals

Continue my own professional development

Present my scientific/academic work

Other: (Please specify)

Participation Other: (Please specify)

Change in Practice

My practice was changed and improved in the following way(s) as a result of the content presented in the course? (Check all that apply)

Diagnostic approach

Therapeutic approach

Disease prevention or health education

System process improvement

No Change

Please check here and explain your choice:

Change in Practice Please check here and explain your choice:

Attend Again

I would attend another MCW Pancreatic Cancer Symposium

Yes

Maybe (Please specify)

Attend Again Maybe (Please specify)

Future Symposium

I think that future symposiums should include:

Commercial Bias

Was the symposium free of commercial bias?

Yes, the content presented was free of commercial bias.

No, there was commercial bias at the symposium. (Please explain)

Commercial Bias No, there was commercial bias at the symposium. (Please explain)

Comments

Please provide any additional comments you may have regarding the symposium:

Leave this field blank

Medical College of Wisconsin

Office of Continuing and Professional Education

2026 26110_MCW Pancreatic Cancer Symposium: Advancing Precision Medicine Evaluation

You are here

2026 26110_MCW Pancreatic Cancer Symposium: Advancing Precision Medicine Evaluation